Lotus Bio Technology Development Stock Performance
| LBTD Stock | USD 0.01 0.00 0.00% |
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Lotus Bio-Technology are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Lotus Bio Technology Development has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Lotus Bio-Technology is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Lotus |
Lotus Bio-Technology Relative Risk vs. Return Landscape
If you would invest 1.00 in Lotus Bio Technology Development on November 4, 2025 and sell it today you would earn a total of 0.00 from holding Lotus Bio Technology Development or generate 0.0% return on investment over 90 days. Lotus Bio Technology Development is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Lotus, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Lotus Bio-Technology Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Lotus Bio-Technology for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Lotus Bio Technology can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Lotus Bio Technology generated a negative expected return over the last 90 days | |
| Lotus Bio Technology has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (19.55 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Lotus Bio Technology Development currently holds about 1 in cash with (17.75 K) of positive cash flow from operations. | |
| Roughly 60.0% of the company outstanding shares are owned by corporate insiders |
Lotus Bio-Technology Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Lotus Pink Sheet often depends not only on the future outlook of the current and potential Lotus Bio-Technology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Lotus Bio-Technology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 82.8 M | |
| Shares Float | 249.1 M |
Lotus Bio-Technology Fundamentals Growth
Lotus Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Lotus Bio-Technology, and Lotus Bio-Technology fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Lotus Pink Sheet performance.
| Return On Asset | -4.21 | |||
| Current Valuation | 31.31 M | |||
| Shares Outstanding | 782.77 M | |||
| Price To Earning | (1.71) X | |||
| Cash And Equivalents | 1 | |||
| Total Debt | 16.68 K | |||
| Cash Flow From Operations | (17.75 K) | |||
| Total Asset | 5.46 K | |||
| Retained Earnings | (931 K) | |||
| Current Liabilities | 68 K | |||
About Lotus Bio-Technology Performance
By analyzing Lotus Bio-Technology's fundamental ratios, stakeholders can gain valuable insights into Lotus Bio-Technology's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Lotus Bio-Technology has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Lotus Bio-Technology has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Lotus Bio-Technology Development Corp., a bio-technology development company, focuses on refining organic materials, and production of natural consumer related products in China. Lotus Bio-Technology Development Corp. was founded in 2011 and is based in Cave Creek, Arizona. Lotus Bio-Technology is traded on OTC Exchange in the United States.Things to note about Lotus Bio Technology performance evaluation
Checking the ongoing alerts about Lotus Bio-Technology for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Lotus Bio Technology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Lotus Bio Technology generated a negative expected return over the last 90 days | |
| Lotus Bio Technology has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (19.55 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Lotus Bio Technology Development currently holds about 1 in cash with (17.75 K) of positive cash flow from operations. | |
| Roughly 60.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Lotus Bio-Technology's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Lotus Bio-Technology's stock is overvalued or undervalued compared to its peers.
- Examining Lotus Bio-Technology's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Lotus Bio-Technology's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Lotus Bio-Technology's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Lotus Bio-Technology's pink sheet. These opinions can provide insight into Lotus Bio-Technology's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Lotus Pink Sheet analysis
When running Lotus Bio-Technology's price analysis, check to measure Lotus Bio-Technology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Bio-Technology is operating at the current time. Most of Lotus Bio-Technology's value examination focuses on studying past and present price action to predict the probability of Lotus Bio-Technology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Bio-Technology's price. Additionally, you may evaluate how the addition of Lotus Bio-Technology to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |